Among 525 newly diagnosed breast cancer patients, 38 patients height >160 cm were excluded, 17 patients with newly diagnosed stage IV breast cancer were excluded, 82 patients with incomplete pathological information and incomplete postoperative treatment information, 73 patients who were lost to follow-up, and a total of 315 patients. Patients with complete follow-up records were enrolled in this study.